|
Loss of Exclusivity |
Central location and TDIs |
n = 75 |
National, Regional and Local payers |
Translation, Recruitment, Moderation, Transcription |
FR; GER; IT; SP; UK |
Pricing and Market Access |
|
Payer perception |
TDIs |
n = 85 |
National, Regional and Local payers |
Translation, Recruitment, Moderation, Transcription |
FR; GER; IT; SP; UK |
Pricing and Market Access |
|
Diabetes |
Central location workshop |
n = 12 |
Payors and payor influenccers |
Recruitment |
GER; IT; UK |
Pricing and Market Access |
|
Pain management |
TDIs |
n = 28 |
Payors and payor influenccers |
Translation, Recruitment, Moderation, Content analysis |
FR; IT; SP; UK |
Pricing and Market Access |
|
Gastric and Breast Cancer |
TDIs |
n = 40 |
National, Regional |
Translation, Recruitment, Moderation, Content analysis |
FR; GER; IT; SP; UK |
Pricing and Market Access |
|
Vaccinations |
TDIs |
n = 30 |
National, Regional and Local payers |
Translation, Recruitment, Moderation, Transcription |
FR; GER; IT; SP; UK |
Pricing and Market Access |
|
Asthma |
TDIs |
n = 30 |
National, Regional, Local payers and payer influencers |
Translation, Recruitment, Moderation, Transcription |
IT; SP; UK |
Pricing and Market Access |
|
NSCLC |
DYADs |
n = 12 |
Payors |
Recruitment and moderation |
FR; IT; UK |
Pricing and Market Access |
|
Oncology workshop |
Central location workshop |
n = 16 |
Payors and payor influenccers |
Recruitment |
FR; IT; SP; UK |
Pricing and Market Access |
|
Hypertension |
TDIs |
n = 40 |
National payors and payor infleuncers |
Translation, Recruitment, Moderation, Content analysis |
FR; GER; IT; SP; UK |
Pricing and Market Access |